PD-1+CD8+T cells as immunological biomarkers for the safe discontinuation of anti-viral therapy in chronic hepatitis B

被引:2
|
作者
Le Bert, N. [1 ]
Rivino, L. [2 ]
Gill, U. S. [3 ]
Cheng, Y. [4 ]
Kunasegaran, K. [2 ]
Tan, D. Z. [1 ]
Becht, E. [4 ]
Hansi, N. K. [3 ]
Foster, G. R. [3 ]
Newell, E. W. [4 ]
Kennedy, P. T. F. [3 ]
Bertoletti, A. [1 ,2 ,4 ]
机构
[1] ASTAR, Singapore Inst Clin Sci, Infect & Immun Program, Singapore, Singapore
[2] Duke NUS Med Sch, Emerging Infect Dis Program, Singapore, Singapore
[3] QMUL, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunobiol,Hepatol, London, England
[4] ASTAR, Singapore Immunol Network, Singapore, Singapore
关键词
D O I
10.1016/S0168-8278(17)31847-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-152
引用
收藏
页码:S687 / S687
页数:1
相关论文
共 50 条
  • [1] Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
    Liang, Y.
    Jiang, J.
    Su, M.
    Liu, Z.
    Guo, W.
    Huang, X.
    Xie, R.
    Ge, S.
    Hu, J.
    Jiang, Z.
    Zhu, M.
    Wong, V. W. -S.
    Chan, H. L. -Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) : 344 - 352
  • [2] IMMUNOLOGICAL AND ANTI-VIRAL THERAPY OF CHRONIC HEPATITIS-B VIRUS-INFECTION
    THOMAS, HC
    BASSENDINE, MF
    CLINICS IN GASTROENTEROLOGY, 1980, 9 (01): : 85 - 95
  • [3] Monitoring peripheral blood PD-1+CD8+T cells to predict response to anti-PD-1 therapy in solid tumors.
    Kim, Kyung Hwan
    Cho, Jinhyun
    Ku, Bo Mi
    Koh, Jiae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Su-Hyung
    Park, Keunchil
    Ahn, Myung-Ju
    Shin, Eui-Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy
    Buti, Maria
    Riveiro-Barciela, Mar
    Esteban, Rafael
    CLINICS IN LIVER DISEASE, 2021, 25 (04) : 725 - 740
  • [5] Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?
    Rijckborst, V.
    Sonneveld, M. J.
    Janssen, H. L. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 501 - 513
  • [6] Anti-viral CD8 T cells and the cytokines that they love
    Cox, Maureen A.
    Kahan, Shannon M.
    Zajac, Allan J.
    VIROLOGY, 2013, 435 (01) : 157 - 169
  • [7] Parallel Session 17: CD8 T Cells in Anti-Viral Immunity and Therapy
    Thimme, R.
    IMMUNOLOGY, 2011, 135 : 29 - 29
  • [8] Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy (vol 34, pg 344, 2011)
    Jiang, J.
    Chan, H. L. -Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (11-12) : 1358 - 1358
  • [9] Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
    Boni, C
    Penna, A
    Bertoletti, A
    Lamonaca, V
    Rapti, I
    Missale, G
    Pilli, M
    Urbani, S
    Cavalli, A
    Cerioni, S
    Panebianco, R
    Jenkins, J
    Ferrari, C
    JOURNAL OF HEPATOLOGY, 2003, 39 (04) : 595 - 605
  • [10] Linear Fidelity in Quantification of Anti-Viral CD8+ T Cells
    Flesch, Inge E. A.
    Hollett, Natasha A.
    Wong, Yik Chun
    Tscharke, David C.
    PLOS ONE, 2012, 7 (06):